Standout Papers

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 cou... 2022 2026 2023 2024172
  1. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study (2022)
    Johan Sundström, Johan Bodegård et al. The Lancet Regional Health - Europe

Immediate Impact

55 standout
Sub-graph 1 of 24

Citing Papers

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
Endocrine Controls of Skin Aging
2025 Standout
3 intermediate papers

Works of Manuel Botana being referenced

The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease
2022
Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from northwest Spain.
2003

Author Peers

Author Last Decade Papers Cites
Manuel Botana 180 194 145 29 574
JS Yudkin 238 154 62 27 552
Linsay McCallum 81 260 125 33 621
Satoshi Iimuro 192 156 69 31 522
Jia‐Sin Liu 165 83 120 35 559
Valeria Frighi 205 89 100 15 548
Yeonhee Lee 83 122 187 34 590
Onofre Vegazo 136 194 65 21 563
Krystyna Widecka 97 161 113 58 464
Simran K. Bhandari 146 288 140 17 508
B Angelkort 211 173 133 32 535

All Works

Loading papers...

Rankless by CCL
2026